Latest dyskinesias Stories
Neuraltus Pharmaceuticals Reports Clinical Results from Phase 1/2 NP002 Study in the Treatment of Dyskinesias Resulting from Levodopa Therapy for Parkinson's Disease
PALO ALTO, Calif., Dec.
Neuraltus Pharmaceuticals Announces Last Patient Out for Studies in ALS and Dyskinesias Associated with the Treatment of Parkinson's Disease
PALO ALTO, Calif., Oct.
Word of the Day
- A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.